StonvexLoading…
StonvexStonvexStonvexCore line items from AAP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Q4 2025 2025-10-04 | Q3 2025 2025-07-12 | Q2 2025 2025-04-19 |
|---|---|---|---|---|
Revenue | $8.60B | $6.63B | $4.59B | $2.58B |
Operating Income | $-43.00M | $-87.00M | $-109.00M | $-131.00M |
Net Income | $44.00M | $38.00M | $39.00M | $24.00M |
EPS (Diluted) | $0.73 | $0.63 | $0.65 | $0.40 |
Total Assets | $11.83B | $12.06B | $10.54B | $10.62B |
Total Liabilities | $9.63B | $9.86B | $8.34B | $8.42B |
Cash & Equivalents | $3.12B | $3.17B | $1.66B | $1.67B |
Free Cash Flow OCF − CapEx | $-298.00M | $-277.00M | $-201.00M | $-198.00M |
Shares Outstanding | 60.00M | 60.00M | 60.00M | 60.00M |